Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Ji-Young Hong"'
Autor:
Yanhua Fan, Huaiwei Ding, Donghwa Kim, Duc-Hiep Bach, Ji-Young Hong, Yongnan Xu, Sang Kook Lee
Publikováno v:
Cancers, Vol 11, Iss 5, p 627 (2019)
Aberrant activation of hepatocyte growth factor (HGF)/c-Met signaling pathway caused by gene amplification or mutation plays an important role in tumorigenesis. Therefore, c-Met is considered as an attractive target for cancer therapy and c-Met inhib
Externí odkaz:
https://doaj.org/article/62be7fd29f1a4837a848c07c21f8d293
Autor:
Hee-Kyoung Kang, Jung-Mi Kwon, Eun-Sook Yoo, Young-Sang Koh, Eun-Ji Kim, Jin-Won Hyun, Min-Kyoung Kim, Jung-Il Kang, Sang-Cheol Kim, Ji-Young Hong, Hye-Jin Boo
Publikováno v:
Marine Drugs, Vol 11, Iss 8, Pp 2982-2999 (2013)
Fucoidan, a sulfated polysaccharide, has a variety of biological activities, such as anti-cancer, anti-angiogenic and anti-inflammatory. However, the mechanisms of action of fucoidan as an anti-cancer agent have not been fully elucidated. The present
Externí odkaz:
https://doaj.org/article/6e7bf00f9174482da03384ee4abf8244
Autor:
Jianyu Liu, Xiao-Sheng Yang, Ji-Young Hong, Sang Kook Lee, Donghwa Kim, Daoping Wang, Yongnan Xu, Huai-Wei Ding, Yanhua Fan
Publikováno v:
Pharmacological research. 160
EPHB6 is a metastasis inhibitory gene that is frequently decreased or deficiency in non-small cell lung cancer (NSCLC), which contributed to the subsequent development of distant metastasis. These suggested the possibility that reactivation of EPHB6
Autor:
Yoosik Kim, Mark Borris D. Aldonza, Jinju Han, Stephanie Tan, Monica Celine Prayogo, Minseok Lee, Ji-Young Hong, Sang Kook Lee, Donghwa Kim, Han Suk Ryu, Sung Gap Im, Seung Jung Yu, Dayeon Kim, Jayoung Ku
Publikováno v:
Science Advances
Paclitaxel failure promotes collateral resistance to EGFR-targeted therapy by adaptive rewiring of the cellular stress response.
Secondary drug resistance stems from dynamic clonal evolution during the development of a prior primary resistance.
Secondary drug resistance stems from dynamic clonal evolution during the development of a prior primary resistance.
Autor:
Ji-Young Hong, Yongnan Xu, Duc-Hiep Bach, Donghwa Kim, Sang Kook Lee, Yanhua Fan, Huai-Wei Ding
Publikováno v:
Cancers
Volume 11
Issue 5
Cancers, Vol 11, Iss 5, p 627 (2019)
Volume 11
Issue 5
Cancers, Vol 11, Iss 5, p 627 (2019)
Aberrant activation of hepatocyte growth factor (HGF)/c-Met signaling pathway caused by gene amplification or mutation plays an important role in tumorigenesis. Therefore, c-Met is considered as an attractive target for cancer therapy and c-Met inhib
Autor:
Ji-Young Hong1, Kenjirou Hara2, Jun-Woo Kim3, Sato, Eisuke F.4, Eun Bo Shim3 ebshim@kangwon.ac.kr, Kwang-Hyun Cho5
Publikováno v:
Korean Journal of Physiology & Pharmacology. Jul2016, Vol. 20 Issue 4, p367-378. 12p.
Publikováno v:
Biomolecules & Therapeutics
Columbianadin (CBN), a natural coumarin from Angelica decursiva (Umbelliferae), is known to have various biological activities including anti-inflammatory and anti-cancer effects. In this study, the anti-proliferative mechanism of actions mediated by
Publikováno v:
Oncotarget
// Song Yi Bae 1 , Ji-Young Hong 1 , Hye-Jung Lee 1 , Hyen Joo Park 1 , Sang Kook Lee 1 1 College of Pharmacy, Seoul National University, Seoul 151–742, Korea Correspondence to: Sang Kook Lee, e-mail: sklee61@snu.ac.kr Keywords: AXL, EGFR-TKI resis
Autor:
Ji-Young Hong1, Geun-Hong Kim1, Jun-Woo Kim1, Soon-Sung Kwon1, Eisuke F. Sato2, Kwang-Hyun Cho3, Eun Bo Shim1 ebshim@kangwon.ac.kr
Publikováno v:
BMC Systems Biology. 2012, Vol. 6 Issue 1, p122-137. 16p. 1 Diagram, 7 Charts, 7 Graphs.
Autor:
Jung-Il Kang, Jung-Mi Kwon, Jin-Won Hyun, Hye-Jin Boo, Min-Kyoung Kim, Eun-Ji Kim, Hee-Kyoung Kang, Ji-Young Hong, Eun-Sook Yoo, Young Sang Koh, Sang-Cheol Kim
Publikováno v:
Marine Drugs, Vol 11, Iss 8, Pp 2982-2999 (2013)
Marine Drugs
Marine Drugs; Volume 11; Issue 8; Pages: 2982-2999
MARINE DRUGS(11): 8
Marine Drugs
Marine Drugs; Volume 11; Issue 8; Pages: 2982-2999
MARINE DRUGS(11): 8
Fucoidan, a sulfated polysaccharide, has a variety of biological activities, such as anti-cancer, anti-angiogenic and anti-inflammatory. However, the mechanisms of action of fucoidan as an anti-cancer agent have not been fully elucidated. The present